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ABSTRACT 
Medication  adherence  is  of  utmost  importance  for  many chronic  
conditions,  regardless  of  the  disease  type.   Engag- ing  patients  
in  self-tracking  their  medication  is  a  big  chal- lenge.  One  way  
to  potentially  reduce  this  burden  is  to  use reminders  to  promote  
wellness  throughout  all  stages  of  life and  improve  medication  
adherence.   Chatbots  have  proven effectiveness  in  triggering  
users  to  engage  in  certain  activ- ity, such as medication adherence.  
In this paper, we discuss “Roborto”,  a chatbot to create an engaging 
interactive and intelligent  environment  for  patients  and  assist  in  
positive lifestyle  modification.   We  introduce  a  way  for  
healthcare providers  to  track  patients  adherence  and  intervene  
when- ever  necessary.   We  describe  the  health,  technical  and  
be- havioural  approaches  to  the  problem  of  medication  non- 
adherence  and  propose  a  diagnostic  and  decision  support tool.    
The  proposed  study  will  be  implemented  and  vali- dated through 
a pilot experiment with users to measure the efficacy of the proposed 
approach. 
 
Categories and Subject Descriptors 
H5.m.  [Information interfaces and presentation (e.g., HCI)]: 
Miscellaneous 
 
General Terms 
Conversational Agent, Behaviour Change, Health 
 
Keywords 
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1.    INTRODUCTION 
Adherence to long-term therapy is when person’s behaviour, such  
as  taking  medication,  following  a  diet,  or  executing lifestyle 
changes, corresponds with agreed recommendations from  a  
healthcare  provider  [13].   Medication  adherence  is 
a  growing  issue  around  the  world.    Among  patients  with chronic 
illness, approximately 50% do not take medications as prescribed.  
Moreover, patients who skip or forgot medica- tion intake as 
prescribed are at risk of health deterioration, increased 
hospitalisation, and mortality.  The World Health Organisation 
WHO reports that increasing the effectiveness of  adherence  
interventions  might  have  a  far  greater  impact on  the  health  of  
the  population  than  any  improvement  in specific medical 
treatment [13].  Sometimes consulting a doc- tor  is  also  an  obstacle  
to  access  the  necessary  advices  on medication adherence. 
Several approaches have been developed to tackle the is- sue of 
medication adherence.  Research studies showed that instant  text  
messaging  could  be  a  good  solution  to  tackle medication  non-
adherence  among  patients  [12,  8].   Unlike apps, messaging 
platforms represented by chatbots are sim- ple,  easy  to  use  and  
requires  no  familiarity  with  the  tool. Moreover,  since  elderly  
people  are  among  the  population that consumes more medication 
and they’re as well more af- fected by low medication adherence 
[13], using a chatbot is a perfect solution to provide them with an 
intuitive technol- ogy.  Moreover, many elderly people are already 
using mes- saging applications, such as Telegram or What’sApp.  
Chat- bots can keep track of patient’s regimen, motivate them to 
keep  going  on  and  can  provide  them  with  side  effects  in- 
formation.   Intelligent  chatbots  can  act  as  miniature  doc- tors  
who  help,  through  AI,  to  find  a  solution  to  common symptoms.   
However,  it’s  worth  saying  that  a  chatbot  will never live up to 
an experienced medical professional and can not provide the human 
touch to cover user emotion and be- havioural needs.  The usefulness 
of chatbots in healthcare is their ability to provide advices and 
information for healthy living.   For  example,  prompt  patient  to  
book  appointment with the doctor for an actual diagnosis.  Chatbots 
can help patients  understand  their  symptom  and  can  facilitate  
the lives  of  many  people,  making  it  easier  to  access  the  neces- 
sary health and medical information. 
With  the  present  article,  we  propose “Roborto”,  a  chat- bot 
model system to increase medication adherence among patients and 
inform healthcare providers about various im- provement and 
deterioration in patient’s condition.  The bot uses natural 
conversation and inline options to help patients understand and 
manage their medication.  Moreover, based on user pre-
configuration, the bot sends them medication re- minder and asks 
them about their health condition and be- havioural  state  (e.g.,  
emotion  and  mood).  Finally,  the  bot design  and  implementation  
is  based  on  a  behavioural  ap- proach to product design.  We 
followed a four steps process
to  design  Roborto  chatbot.   The  four  stages  of  behaviour design  
focus  on  attention,  influencing  decision,  facilitating action  and  
sustaining  the  behaviour.    To  the  best  of  our knowledge,  few 
works with scientific validations and proofs discussed chatbot 
application for medication adherence. 
 
2.    BACKGROUND 
Engaging people in their health and supporting them with self-
management  techniques  are  a  rational  to  educate  pa- tients about 
their health condition.  However, self-management interventions  
often  fail  to  show  significant  improvement  in care.   The  
intervention  fails  at  different  stages,  due  to  ad- herence problems 
which can relate to user behaviour or the technology  context.  A  
work  by  Monkaresi  et  al.,  [9]  devel- oped an interactive 
environment to assist diabetes patients 
in positive lifestyle modification and increase their medica- tion  
adherence.   The  study  investigated  different  dialogue styles  and  
interaction  design  aspects,  informed  by  motiva- tional theories 
and found a correlation between patients ad- herence and dialogue 
style. 
Short  Messaging  Service  (SMS)  is  among  the  widely  ap- 
plied  approaches  to  increase  medication  adherence.    SMS has  
been  studied  for  a  variety  of  disorders  from  medical  to surgical 
specialities.  These studies evaluated text reminder schedules  
ranging  from  multiple  times  a  day,  once  daily  to less frequent 
once weekly SMS [16].  In a review by Sarkar et al., [16] utilised 
SMS text to promote medication adherence for  a  range  of  health  
conditions  including  self-reported  ad- herence,  pill  counts  and  
biochemical  measures.   The  study suggested the potential role of 
SMS reminders in the emerg- ing developing economies.  The 
findings showed that SMS re- minders have been largely positive.  
Perhaps this enthusiasm of short message system (SMS) text 
messaging to engage pa- tients in their own healthcare has been due 
to relatively low cost,  portability  and  widespread  use  of  these  
technologies. There  is  compelling  evidence  mHealth  can  improve  
adher- ence to medications and suppress viral loads in patients with 
chronic conditions.  Lauffenburger et al., [6] conducted ran- 
domised  controlled  trial  on  patients  with  high  blood  pres- sure 
in Cape Town, South Africa.  The study tested 2 differ- ent text 
messaging systems, unidirectional information-only messages  and  
2-way  interactive  messages,  among  1372  pa- tients of mostly 
black African or mixed ancestry.  The study developed a bank of 
text-messages that they mapped to be- havioural  change  
techniques,  including  goals  and  planning, repetition and 
substitution, social support, and natural con- sequences.  Chat and 
messaging platform offer great advan- tages  in  the  context  of  
mHealth  paradigm.  The  rapid  evo- lution of such technologies 
have opened a niche for doctor- patient  (DP)  communication,  by  
providing  a  high  popula- tion  penetration  rate  with  perfect  
personalisation  capabil- ities.   Abashev  et  al.,  [1]  provided  a  
model  for  a  chatbot system  that  integrates  machine  conversation  
systems  sup- plemented by natural spoken language in mHealth 
devices. The  study  suggested  applying  these  technologies  
together with module apps is a good solution for a variety of transla- 
tional and outpatients medicine tasks.  The study concluded that 
using chatbot systems in doctor-patient communication can reduce 
costs and time on routine operations.  Conversely, a study by Liu et 
al., [8] applied mobile text messaging and medication  monitors  to  
improve  the  adherence  to  tubercu- losis  (TB)  treatment.  The  
findings  showed  that,  in  China, the electronic medication monitor 
box improved patients ad- 
herence to take their antituberculosis drugs.  However, text 
messaging  alone,  which  has  been  shown  to  improve  adher- ence  
to  antiviral  therapy  among  HIV-patients,  did  not  im- prove  
medication  adherence  among  patients  with  tubercu- losis.    The  
authors  linked  this  to  the  messages  being  too frequent  or  too  
impersonal,  although  this  intervention  did reduce  patient  loss  to  
follow  up.   Text  messaging  as  elec- tronic reminders provide an 
opportunity to improve medica- tion adherence.  In a systematic 
review by Sarabi et al., [14] they  investigated  evidence  to  prove  
whether  text-message reminders were effective in improving 
patients’ adherence to medication.  The study indicated that text-
messaging inter- ventions have improved patients’ medication 
adherence rate (85%,  29.34).  The  most  common  study  design  
was  carried out in the developed countries. 
Personalised text message reminders can support mHealth 
interventions also among patients following release from the 
hospital  to  support  their  cure  process  and  medication  ad- 
herence.   Park  et  al.,  [11]  evaluated  text  messaging  as  re- 
minder for medication among patients with Coronary Heart Disease 
CHD after being released from hospital.  The result suggested 
mHealth may be useful for improving medication adherence during 
the vulnerable time for CHD patients fol- lowing  discharge  from  
the  hospital.  Similarly,  Challenor  et al., [3] found that mobile text 
messaging was by far the most popular method patients wished to 
be contacted with (62%) during any mHealth intervention. 
Using  chat  based  communication  comes  with  challenges 
related to the level of complexity of the language associated with  
the  task,  integrating  a  dialogue  system  with  a  com- plex  backend  
reasoning,  intention  recognition  as  key  part of  the  understanding  
process,  and  finally,  the  challenges  of mixed initiative where 
either user or system can control the dialogue  at  different  times  to  
achieved  effective  interaction [2].    Shang  et  al.,  [15]  proposed  
Neural  Responding  Ma- chine  (NRM),  a  neural  network-based  
response  generator for  Short-Text  Conversation.   The  NRM  takes  
the  general encoder-decoder  framework,  it  formalises  the  
generation  of response  as  a  decoding  process  based  on  the  
latent  repre- sentation of the input text.  The study proved NRM to 
gen- erate  grammatically  correct  and  content-wise  appropriate 
responses to over 75% of the input text.  A study by Liu et al., [7] 
investigated evolution metrics for end-to-end dialogue systems 
where supervised label, such as task completion are not  available.   
The  study  found  these  metrics’s  correlated weakly  with  human  
judgments  of  response  quality  in  both technical  and  non-
technical  domains.   The  study  provided future  recommendations  
for  a  better  automatic  evaluation metrics for dialogue systems. 
Discussion:  The majority of studies applied Short Mes- saging  
Service  (SMS)  to  adhere  patients  to  their  medica- tion  dosages.    
Moreover,  there  was  almost  no  study  that adapted  conversational  
interfaces  into  their  mHealth  inter- vention.   This  could  be  due  
to  the  new  field  of  conversa- tional  user  interface  which  is  still  
growing  and  researchers haven’t  harnessed  the  full  potential  of  
this  promising  tech- nology  as  an  alternative  to  mobile  
applications.   Although the  positive  findings  associated  with  the  
SMS  adaption  in patient  support  and  medication  adherence,  to  
our  knowl- edge  there  are  several  limitations  associated  with  
SMS  as an  mHealth  tool.   Conversely,  adapting  chatbots  can  
pro- vide a major shift to support mHealth interventions in this 
domain.  To begin,  SMS is an effective reminder tool,  how-
ever unlike chatbots, it has no educational, motivational and support  
capabilities.   For  example,  a  chatbot  can  provide more 
personalised reminders and instruction and provide pa- tient 
adherence data to the doctor to highlight any patient improvement  
or  deterioration  with  respect  to  the  medica- tion  and  disease.   
Short  messaging  services  provide  imper- sonal reminder and 
instructions and could be too frequent. Whereas,  chatbots  could  
provide  advanced  feature  integra- tion  (e.g.,  machine  learning  
models),  its  expandable,  and most  importantly,  its  cost  effective,  
user-age  friendly  (e.g., easier  for  elderly  to  use),  since  it  has  
low  learning  curve and doesn’t require extra 
installation/configuration.  Unlike SMS, chatbots can track/report 
patient performance to the healthcare provider.  Finally,  chatbots 
are good approaches to support healthcare systems in developing or 
under devel- oped countries (e.g., in rural African villages) to 
provide low cost healthcare services to the citizens living  there.  To 
the best of our knowledge, the vast majority of studies focused on 
SMS in their services, and non have considered chatbots to  provide  
richer  and  innovative  solution  to  support  their mHealth 
intervention. 
 
3.    RESEARCH GOAL 
This research is highly interdisciplinary, involving health, 
technology and user behaviour and emotional state.  One of the 
common rationales for using chatbots is that they sup- port patient 
engagement.  With this paper, we aim to estab- lish  patient-doctor  
interaction  environment  for  healthcare service  delivery  with  a  
simple  chatbot  +  web  application based mHealth intervention tool. 
We intend to integrate the chatbot with other healthcare 
application  for  the  purpose  of  producing  personalised  rec- 
ommendations  and  tracking  patient  condition  overtime  by the  
healthcare  provider.   Thus,  with  this  research  we  tend to answer 
the following research questions: 
 
•  How to overcome the issue of medication non-adherence? 
 
•  What is the design approach most motivating for pa- tients? 
 
•  What  are  the  design  features  with  significant  impact on  
medication  adherence  (e.g.,  digital  experience,  so- cial 
factor, behavioural techniques)? 
 
With  these  questions  we  will  also  answer  the  most  routine 
issues faced by patients with low medication adherence, in- cluding 
exercise, nutrition, emotional state, stress level, and sleeping  
pattern.    The  chatbot  is  particularly  focused  on forgetfulness  as  
the  primary  barrier  to  optimal  medication adherence. 
 
4.    APPROACH 
The  approach  is  to  engage  healthcare  providers  to  expe- 
rience the effective use of conversational AI to empower pa- tients 
to use chatbots as an enabling tool.  In this way,  pa- tients can be 
more responsible for their health and adhered to  their  medication.  
The  chatbot  system  offers  a  potential way to help patients adhere 
to their treatments by introduc- ing awareness, and guidance into 
their routine. 
One distinguishing feature in “Roborto” chatbot is the in- clusion 
of human backup in the process.  The reason is that automated 
systems can’t respond well to patients need, spe- cially  when  they  
feel  trapped  at  certain  point  during  their 
treatment journey.  For example, when a patient asks a hy- brid 
system for a customer support, in order for the system to redirect the 
user to a real agent it asks the user a set of te- dious questions to 
better support their inquiries.  Whereas, including a real healthcare 
provider to track patients condi- tion can also support them with 
empathy while making sure users are helped quickly. 
 
4.1    Chatbot Behavioural Design Process 
Dealing  with  patients  medication  adherence  is  strongly 
correlated  to  their  behaviour,  therefore  we  should  link  the 
targeted actor of the application, with the process and out- put.  In  
this  way  we  can  guide  design  process  and  evaluate the 
behavioural effectiveness of the chatbot.  Below we will define  each  
of  the  targeted  actor,  process  and  output.   We then provide the 
stages of behavioural design to ensure the chatbot is as engaging, 
persuasive, and actionable as possi- ble [17]. 
Actor:   Who  are  the  envisioned  users  who  will  do  some- thing  
different  in  their  lives,  and  accomplish  the  intended output?.  
For example, patients with chronic conditions who are required to 
adhere to a certain medication to avoid the deterioration of their 
health condition. 
Process:  How  will  the  patient  achieve  the  medication  ad- 
herence  and  what  behaviour  will  they  undertake?.  For  ex- 
ample,  patients  medication  data  will  be  provided  to  the bot,  
and  the  patient  will  be  triggered  whenever  its  med- ication  time  
to  report  their  adherence  and  other  medical, behavioural and 
psychological conditions.  This step will be mostly covered by the 
behaviour design process. 
Output:   What  is  the  goal  we  intend  to  achieve  with  the 
chatbot?.  For example, people with type 2 diabetes will be more  
adhered  to  their  insulin  dosages  when  the  chatbot  is in action. 
 
 
4.1.1    The Stages of Behaviour Design 
With this step we clarify the overall behavioural vision of the 
chatbot, identify the patients outcomes sought, provide a list of 
possible actions, understand patients and what is fea- sible and 
interesting to them, and evaluate the list of possible actions.  To 
achieve this, we will follow a four-stages frame- work to guide our 
chatbot design and development process [10](see Figure-1). 
 
 
 
Figure  1:  Chatbot  Stages  of  Behaviour  Design. 
 
 
1.  Trigger  Attention:  The  first  thing  is  to  consider  how to  
attract  users  to  use  the  application.   Why  should
healthcare providers or patients use the chatbot?.  There- fore, 
the bot should trigger user attention.  To achieve this, we need 
to draw people into the bot with engaging storytelling, and 
compelling motion design.  Moreover, the  bot  should  provide  
elicit  an  emotional  reaction, such  as  surprise,  curiosity,  or  
urgency.   The  chatbot should  personalise  the  content  and  
make  it  relevant and based on users behaviour, interest and 
value. 
 
2.  Influence Decisions:  The chatbot has to present clear 
argument that nudges them to take action.  Therefore, we  
should  provide  clear,  straightforward  content  and make  the  
message  specific,  simple  and  help  patients make an 
informed choice.  Offer recommendations and make the 
content compelling to patients. 
 
3.  Facilitate Action:  At this stage we should help patients follow 
through, by creating as easy and barrier-free ac- tion as 
possible.  This is achievable by breaking down the  action  into  
small,  achievable  steps.    We  should identify and address 
common barriers that prevent pa- tients from taking action.  
To facilitate the action, one should guide the experience of 
patient in a certain way. Encourage patients to set goals and 
commit to actions by sending reminders and follow up on 
their progress. 
 
4.  Sustain  New  Behaviour:   Finally,  to  achieve  a  long- lasting 
impact of medication adherence, we should mo- tivate  
patients  continue  the  behaviour  and  feel  the sense  of  
progress.    Emphasising  intrinsic  motivation can be a 
technique to build long term behaviour change. Research  
shows  that  people  are  drawn  to  experiences that  give  them  
a  sense  of  purpose,  social  connection, status, and self 
expression. 
Applying this model of behavioural staging helps iden- tify 
what stages in the journey are working and which could be 
better strengthening our designs and mitigat- ing the risk of 
application abandonment. 
 
4.2    Roborto Chatbot Functionalities 
The  bot  functionalities  need  to  accommodate  complex data 
interaction, where user experience design means mak- ing a 
completely new concept that fits with user behaviour and condition.  
The chatbot supports adding a medication, where patients can 
identify medicine by name, icon, or photo. The bot sets a reminder 
about medication time and quantity. When  its  medication  time,  the  
bot  prompts  a  card  within the  chatbot  asking  user  to  report  
their  medication  adher- ence,  based  on  which  they  are  provided  
with  a  feedback. Besides medication, the bot asks users about any 
symptoms and their overall stress level, emotion/mood and sleep pat- 
tern.    In  addition,  patients  can  record  their  exercise  and dietary 
type and other disease related information.  Finally, the bot provides 
a report of patients condition and adherence to the healthcare 
providers who can track and intervene with the  user  via  a  chat  
window  wherever  relevant.  The  overall functionalities in Roborto 
bot are as summarised below: 
 
•  Evaluation  of  condition  by  asking  the  patient  to  pro- vide 
a list of information to track their state of health and 
medication adherence. 
 
•  Tailored reminder about the necessary procedures and 
medication adherence, doctor appointment and visit. 
•  External asynchronous chat with healthcare providers through 
a chat channel [5]. 
 
•  Doctor  appointment  remotely  for  medical  procedure 
through a chat interface with a few button clicks. 
 
•  mHealth data collection about patient medication ad- herence, 
condition, and disease related parameters, such as sleep, 
feeling, diet, and physical activity.  These data are  forwarded  
to  the  healthcare  provider  who  tracks their patients via a 
web application. 
 
•  The healthcare provider can intervene and provide pa- tient  
with  feedback  on  how  to  improve  their  overall condition,  
by  taking  into  account  the  parameters  of their  behavioural  
patterns  (nutrition,  physical  activ- ity),  for  them  to  adjust  
their  behaviour  to  the  preset target indicators [4, 5]. 
 
•  The bot can also provide information about a disease with 
causes and health tips and recommendations for 
improvements. 
 
4.3    Chatbot Design 
The chatbot detects the time and quantity of medication. It asks 
the user follow-up questions to determine their opti- mal reminder 
time.  At the design phase, we focus on simple interaction and letting 
patients choose their optimal timing for reminder and other data 
entry.  The bot provides quick replies to ease the bot-patient 
interaction.  Designing a sys- tem that is smart to predict behaviour 
and that is utilitarian and  yet  engaging  can  get  extremely  hard.   
Beside  friendli- ness,  we  also  focused  on  motivation,  empathy,  
discretion, and  relevance  while  designing  the  bot  UI.  In  Figure-
2  we provide an overview of the chatbot medication reminder. 
 
 
 
Figure  2:  The  Roborto  Conversational  Interface.
 
 
Figure  3:  The  Roborto  Chatbot  Architecture. 
 
4.4    Chatbot Architecture 
This phase focused on combining the technologies and de- sign 
aspects together to achieve efficient medication adher- ence.   For  
the  implementation,  we  developed  a  chatbot  for the patient to 
track and report their medication, health and emotional  condition,  
along  with  other  lifestyle  related  pa- rameters (e.g.,  diet and 
exercise).  However,  a web applica- tion is developed for the 
healthcare provider to track patient condition and intervene 
whenever relevant. 
We used the Telegram bot API1  for the bot application to connect 
the bot to our system.  The API provides interme- diary server that 
handles all encryption and communication with  the  Telegram  API.  
The  application  can  communicate with  this  server  via  a  simple  
HTTPS-interface  that  offers a simplified version of the Telegram 
API. At the core, mes- sages, commands and requests sent by users 
are passed to the software running on application server.  To enrich 
the bot in- telligence we use the Microsoft Bot Framework2, in this 
way the bot acts more human like and responds more intelligently 
to specific user inquiries.  The bot framework providers web- 
services with intelligence and connection using the conversa- tion 
channel the user authorises.  The disease, symptoms and medical 
information were all retrieved from the APiMedic3. This API 
provides the knowledge base to our chatbot.  For example,  symptom  
checker  API  allows  the  integration  of symptom  checker  
functionalities  into  the  bot,  allowing  pa- tients  to  find  out  what  
possible  diseases  they  might  have. The  integrated  application  
also  directs  users  to  more  med- 
 
1https://core.telegram.org/bots 
2https://dev.botframework.com/ 
3http://apimedic.com/ 
ical  information.   We  developed  the  web  application  using Ruby 
and Ruby on Rails Framework4, since it provides flex- ibility  and  
fast  development  environment.   In  Figure-3  we provide  the  high-
level  architecture  of  the  Roborto  chatbot application architecture. 
 
4.5    Contribution 
There is a vast proliferation of technology available which could 
be useful in healthcare.  In even less developed coun- tries, people 
are increasingly using smartphone and have ac- cess to a lot of 
information.  However,  we need a simplified way  to  to  access  
these  information.   Conversational  inter- faces offer the solution 
we need in this regard.  A chatbot can provide patients with 
clinically validated information about diseases educational material 
or info about newly prescribed medication.  All the patient has to do 
is start chatting with the bot. 
In healthcare, a vast time is spent generating and retriev- ing 
information.  For example, doctors diagnose based on the symptoms 
the patient describes, or home care services need consistent  
information  about  the  health  situation  of  their patients.   A  
chatbot  can  support  physicians  and  nurses  by collecting the right 
information and, therefore, increase the efficiency of the overall 
healthcare system (quicker, cheaper, more  accurate).   Moreover,  
patients  who  track  medication need to track other parameters, such 
as sleep, diet and feel- ing,  a chatbot can combine all these processes 
and make it accessible via a chat or few button clicks. 
With this research, we provide a guided conversation that 
provides users with predefined answers integrated into their 
 
4http://rubyonrails.org/
Telegram  chat  application.   Hence,  we  contribute  by  pro- viding  
a  tool  to  trigger  patients  for  medication  adherence and for 
healthcare providers to track patients adherence and overall  health  
condition.   Moreover,  rather  than  just  a  re- minder, we included 
a human actor into the loop to respond well  to  patient’s  emotional  
condition.  Unlike  mobile  appli- cations, the chatbot has a simple 
interface which eliminates technology difficulties due to age 
barriers.  Finally, since the bot collects data beyond medication 
adherence, it acts as a medication reminder and health condition 
tracker. 
 
5.    WHY ROBORTO CHATBOT? 
The  chatbot  acts  as  a  support  tool  and  doesn’t  substi- tute 
professional medical advices.  The Roborto chatbot in- tends to 
generate recommendations based on user informa- tion.  The bot 
interface provides patients with reminders and follow-up questions 
to better predict their condition and in- form  the healthcare  provider  
about  patients overall  health. On  the  other  hand,  the  healthcare  
provider  is  given  a  web application dashboard to monitor the 
history of patients ac- tivities,  goals  and  medications.   The  aim  
of  the  developed web  +  chatbot  application  is  to  provide  an  
approach  and adopt the chatbot to motivate, educate and engage 
patients in  managing  their  own  health  with  a  simple,  cost  
effective technology.  Hence, we believe this approach to improve 
ad- herence  to  treatment  plans  in  patients  with  chronic  condi- 
tions,  through encouragement,  reminders and regular chat- ting  
with  healthcare  providers.   The  chatbot  collects  data and provides 
instant feedback about patients condition, en- gage  patients  in  their  
own  health  and  improve  outcomes, determine the cost 
effectiveness of this virtual clinic consul- tation strategy. 
 
6.    DISCUSSION 
Conversational  interfaces  can  either  collect  information 
from/for users or provide or help users with some tasks.  In this 
paper we discussed“Roborto”, a chatbot case to improve patients 
adherence to medication.  We have a number of limi- tations that we 
intend to tackle in future work.  For example, providing patients with 
information about a symptom they checked is often complicated, 
since there is a lot of content and its hard to scroll and read the whole 
text, which is often confusing.  We  will  implement  a  functionality  
to  show  only part of the text and ask user to click in case they intend 
to read more.  This way they get only as much information as they  
wants  to  read.   It  is  crucial  to  consider  patients  feel- ing when 
dealing with their adherence, patients need to be supported,  not  
blamed.   For  future  work,  we  intend  to  in- tegrate  machine  
learning  to  understand  patients  treatment and effective care.  We 
also intend to integrate the bot with wearable  technologies  to  ease  
the  process  of  medication  re- minder  and  tracking.   Finally,  to  
extract  patient  intention, we will use machine learning intelligence 
such that, when the user says a sentence as:  “I am having a 
headache”,  the bot can  extract  user  intention  and  provide  them  
with  a  mean- ingful  feedback.   This  could  require  further  
research,  since patients often describe symptoms in very different 
ways and often don’t know the medical terms. 
 
7.    CONCLUSIONS 
In this paper we presented a chatbot application to adhere patients  
to  their  medication.   The  presented  model  of  the 
chatbot  system  provides  an  innovative  approach  to  adhere 
patients medication and track their condition overtime.  Im- proving  
patients  adherence  might  be  the  best  approach  for tackling  
chronic  conditions  effectively.   A  multidisciplinary approach 
towards adherence is needed and we need to track not  only  patients  
adherence  to  medication,  but  also  their various lifestyle related 
activities and most importantly their emotional state.  We have 
covered this study from technical, medical and behavioural points.  
The next step is to develop the complete prototype and conduct a 
pilot study to evalu- ate the effectiveness of the proposed system. 
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